ABCG2 Transports and Transfers Heme to Albumin through Its Large Extracellular Loop

被引:80
作者
Desuzinges-Mandon, Elodie [1 ]
Arnaud, Ophelie [1 ]
Martinez, Lorena [1 ]
Huche, Frederic [1 ]
Di Pietro, Attilio [1 ]
Falson, Pierre [1 ]
机构
[1] Univ Lyon 1, UMR CNRS 5086, IBCP,Equipe Labellise Ligue 2009, ABC Transporters & Multidrug Resistance Lab,IFR 1, F-69367 Lyon, France
关键词
CANCER RESISTANCE PROTEIN; CIRCULAR-DICHROISM SPECTRA; ETCH VIRUS PROTEASE; MULTIDRUG TRANSPORTER; SECONDARY STRUCTURE; EFFLUX PUMP; CELL-LINES; STEM-CELLS; DIFFERENTIATION; INHIBITION;
D O I
10.1074/jbc.M110.139170
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
ABCG2 is an ATP-binding cassette (ABC) transporter preferentially expressed by immature human hematopoietic progenitors. Due to its role in drug resistance, its expression has been correlated with a protection role against protoporhyrin IX (PPIX) accumulation in stem cells under hypoxic conditions. We show here that zinc mesoporphyrin, a validated fluorescent heme analog, is transported by ABCG2. We also show that the ABCG2 large extracellular loop ECL3 constitutes a porphyrin-binding domain, which strongly interacts with heme, hemin, PPIX, ZnPPIX, CoPPIX, and much less efficiently with pheophorbide a, but not with vitamin B12. K-d values are in the range 0.5-3.5 mu M, with heme displaying the highest affinity. Nonporphyrin substrates of ABCG2, such as mitoxantrone, doxo/ daunorubicin, and riboflavin, do not bind to ECL3. Single-point mutations H583A and C603A inside ECL3 prevent the binding of hemin but hardly affect that of iron-free PPIX. The extracellular location of ECL3 downstream from the transport sites suggests that, after membrane translocation, hemin is transferred to ECL3, which is strategically positioned to release the bound porphyrin to extracellular partners. We show here that human serum albumin could be one of these possible partners as it removes hemin bound to ECL3 and interacts with ABCG2, with a K-d of about 3 mu M.
引用
收藏
页码:33123 / 33133
页数:11
相关论文
共 58 条
[1]
Flavonoid structure-activity studies identify 6-prenyichrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2 [J].
Ahmed-Belkacem, A ;
Pozza, A ;
Muñoz-Martínez, F ;
Bates, SE ;
Castanys, S ;
Gamarro, F ;
Di Pietro, A ;
Pérez-Victoria, JM .
CANCER RESEARCH, 2005, 65 (11) :4852-4860
[2]
Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors [J].
Ahmed-Belkacem, Abdelhakim ;
Macalou, Sira ;
Borrelli, Francesca ;
Capasso, Raffaele ;
Fattorusso, Ernesto ;
Taglialatela-Scafati, Orazio ;
Di Pietro, Attilio .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (08) :1933-1938
[3]
Allen JD, 2002, MOL CANCER THER, V1, P417
[4]
EVALUATION OF SECONDARY STRUCTURE OF PROTEINS FROM UV CIRCULAR-DICHROISM SPECTRA USING AN UNSUPERVISED LEARNING NEURAL-NETWORK [J].
ANDRADE, MA ;
CHACON, P ;
MERELO, JJ ;
MORAN, F .
PROTEIN ENGINEERING, 1993, 6 (04) :383-390
[5]
MECHANISM OF DIFFERENTIATION OF HUMAN ERYTHROLEUKEMIC CELL-LINE K-562 BY HEMIN [J].
BALIGA, BS ;
MANKAD, M ;
SHAH, AK ;
MANKAD, VN .
CELL PROLIFERATION, 1993, 26 (06) :519-529
[6]
Oligomerization of the human ABC transporter ABCG2:: Evaluation of the native protein and chimeric dimers [J].
Bhatia, A ;
Schäfer, HJ ;
Hrycyna, CA .
BIOCHEMISTRY, 2005, 44 (32) :10893-10904
[7]
Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec®) across the mouse blood-brain barrier [J].
Bihorel, Sebastien ;
Camenisch, Gian ;
Lemaire, Michel ;
Scherrmann, Jean-Michel .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 (06) :1749-1757
[8]
Acridone derivatives: Design, synthesis, and inhibition of breast cancer resistance protein ABCG2 [J].
Boumendjel, Ahcene ;
Macalou, Sira ;
Ahmed-Belkacem, Abdelhakim ;
Blanc, Madeleine ;
Di Pietro, Attilio .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (08) :2892-2897
[9]
Dean M, 2001, J LIPID RES, V42, P1007
[10]
TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77